Geovax Labs Inc logo

Geovax Labs Inc

0
NAS:GOVX (USA)  
$ 2.01 +0.02 (+1.01%) 12:08 AM EST
At Loss
Market Cap:
$ 17.09M
Enterprise V:
$ 15.54M
Volume:
285.37K
Avg Vol (2M):
1.03M
Trade In:
Volume:
285.37K
At Loss
Avg Vol (2M):
1.03M

Business Description

Description
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 11
Equity-to-Asset -0.56
Debt-to-Equity -0.06
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -60.18
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.13
9-Day RSI 40.23
14-Day RSI 40.13
6-1 Month Momentum % 70.14
12-1 Month Momentum % -67.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.6
Quick Ratio 0.6
Cash Ratio 0.24
Days Sales Outstanding 365

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -97.8
Name Current Vs Industry Vs History
Operating Margin % -9049.5
Net Margin % -8941.86
FCF Margin % -7640.86
ROE % -451.73
ROA % -248.36
ROIC % -2665.79
3-Year ROIIC % -2267.87
ROC (Joel Greenblatt) % -13508.93
ROCE % -457.1

Financials

GOVX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GOVX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Geovax Labs Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.301
EPS (TTM) ($) -13.2
Beta 3.97
Volatility % 177.54
14-Day RSI 40.13
14-Day ATR ($) 0.25848
20-Day SMA ($) 2.08375
12-1 Month Momentum % -67.33
52-Week Range ($) 1.0901 - 11.18
Shares Outstanding (Mil) 8.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Geovax Labs Inc Filings

Filing Date Document Date Form
No Filing Data

Geovax Labs Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Geovax Labs Inc Frequently Asked Questions

What is Geovax Labs Inc(GOVX)'s stock price today?
The current price of GOVX is $2.01. The 52 week high of GOVX is $11.18 and 52 week low is $1.09.
When is next earnings date of Geovax Labs Inc(GOVX)?
The next earnings date of Geovax Labs Inc(GOVX) is .
Does Geovax Labs Inc(GOVX) pay dividends? If so, how much?
Geovax Labs Inc(GOVX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1